Related references
Note: Only part of the references are listed.Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking
Paramananthan Mariappan et al.
BJU INTERNATIONAL (2012)
Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder
Kirk A. Keegan et al.
CURRENT OPINION IN ONCOLOGY (2012)
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
Nicholas D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Screening for Bladder Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2011)
Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up
Thomas J. Edwards et al.
BJU INTERNATIONAL (2011)
Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience
Faysal A. Yafi et al.
BJU INTERNATIONAL (2011)
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy
Harry W. Herr et al.
BJU INTERNATIONAL (2011)
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard
Bjorn L. Isfoss
BJU INTERNATIONAL (2011)
Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study
Gregers G. Hermann et al.
BJU INTERNATIONAL (2011)
Detection and Clinical Outcome of Urinary Bladder Cancer With 5-Aminolevulinic Acid-Induced Fluorescence Cystoscopy A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
Arnulf Stenzl et al.
CANCER (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial)
Tim O'Brien et al.
EUROPEAN UROLOGY (2011)
Trends in Mortality From Urologic Cancers in Europe, 1970-2008
Cristina Bosetti et al.
EUROPEAN UROLOGY (2011)
The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review
Rianne J. M. Lammers et al.
EUROPEAN UROLOGY (2011)
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis
Graham Mowatt et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2011)
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Neal D. Freedman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
Ananya Choudhury et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
Gareth Griffiths
JOURNAL OF CLINICAL ONCOLOGY (2011)
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial
Savino M. Di Stasi et al.
LANCET ONCOLOGY (2011)
Lymphadenectomy for Bladder Cancer: Indications and Controversies
Fiona C. Burkhard et al.
UROLOGIC CLINICS OF NORTH AMERICA (2011)
Perioperative Mortality Is Significantly Greater in Septuagenarian and Octogenarian Patients Treated With Radical Cystectomy for Urothelial Carcinoma of the Bladder
Daniel Liberman et al.
UROLOGY (2011)
Impact of gender on bladder cancer incidence, staging, and prognosis
Harun Fajkovic et al.
WORLD JOURNAL OF UROLOGY (2011)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer (vol 17, pg v118, 2006)
Hans von der Maase et al.
ANNALS OF ONCOLOGY (2011)
Failure of bacille Calmette-Guerin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options
David R. Yates et al.
BJU INTERNATIONAL (2010)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
Ingo Kausch et al.
EUROPEAN UROLOGY (2010)
Transurethral Resection of Non-Muscle-Invasive Bladder Transitional Cell Cancers With or Without 5-Aminolevulinic Acid Under Visible and Fluorescent Light: Results of a Prospective, Randomised, Multicentre Study
Martin C. Schumacher et al.
EUROPEAN UROLOGY (2010)
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2010)
An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer
Girish S. Kulkarni et al.
EUROPEAN UROLOGY (2010)
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
G. Mowatt et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
Mohamed S. Zaghloul et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
Peter J. Hoskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
Arnulf Stenzl et al.
JOURNAL OF UROLOGY (2010)
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
Giacomo Novara et al.
JOURNAL OF UROLOGY (2010)
Narrow Band Imaging Cystoscopy Improves the Detection of Non-muscle-invasive Bladder Cancer
Evelyne C. C. Cauberg et al.
UROLOGY (2010)
Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer
Guido Dalbagni et al.
EUROPEAN UROLOGY (2009)
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
Ahmad Shabsigh et al.
EUROPEAN UROLOGY (2009)
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Per-Uno Malmstrom et al.
EUROPEAN UROLOGY (2009)
A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)
Dongmei Qiu et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Case-Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
Dalsu Baris et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
LONG TERM SURVIVAL OUTCOME FOLLOWING RADICAL CYSTECTOMY FOR TCC OF THE BLADDER - COMPARISON BETWEEN PRIMARY AND SALVAGE RADICAL CYSTECTOMY
Sanjai K. Addla et al.
JOURNAL OF UROLOGY (2009)
Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
Ofer Nativ et al.
JOURNAL OF UROLOGY (2009)
Quality of Life and Body Image for Bladder Cancer Patients Undergoing Radical Cystectomy and Urinary Diversion-A Prospective Cohort Study With a Systematic Review of Literature
Bhaskar K. Somani et al.
UROLOGY (2009)
Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(A (R)) working party
J. Alfred Witjes et al.
WORLD JOURNAL OF UROLOGY (2009)
Assessment and management of non-visible haematuria in primary care
John D. Kelly et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Quality control in transurethral resection of bladder tumours
Harry W. Herr et al.
BJU INTERNATIONAL (2008)
The changing patterns of bladder cancer in Egypt over the past 26 years
Ashley S. Felix et al.
CANCER CAUSES & CONTROL (2008)
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: Do risk factors define feasibility of bladder-sparing approach?
Stefan Denzinger et al.
EUROPEAN UROLOGY (2008)
Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center
Sanjeev Kotwal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Contemporary open radical cystectomy: Analysis of perioperative outcomes
William T. Lowrance et al.
JOURNAL OF UROLOGY (2008)
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Lambertus A. Kiemeney et al.
NATURE GENETICS (2008)
Intravesical treatments of bladder cancer: Review
Zancong Shen et al.
PHARMACEUTICAL RESEARCH (2008)
Frequency and surgical management of chronic complications related to pelvic radiation
Matthias Turina et al.
ARCHIVES OF SURGERY (2008)
Micropapillary bladder cancer - A review of the University of Texas MD Anderson Cancer Center experience with 100 consecutive patients
Ashish M. Kamat et al.
CANCER (2007)
Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study
Jeanine M. Genkinger et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
Harry W. Herr et al.
JOURNAL OF UROLOGY (2007)
Cancer incidence after localized therapy for prostate cancer
Kihyuck Moon et al.
CANCER (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic
TJ Edwards et al.
BJU INTERNATIONAL (2006)
Occult bleeding in three different antithrombotic regimes after myocardial infarction A WARIS-II subgroup analysis
Mette Hurlen et al.
THROMBOSIS RESEARCH (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor
J Palou et al.
JOURNAL OF UROLOGY (2005)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer:: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas et al.
LANCET (2005)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomised trial of accelerated radiotherapy for localised invasive bladder cancer
A Horwich et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma
V Ficarra et al.
BJU INTERNATIONAL (2005)
Do cancer Centers designated by the National Cancer Institute have better surgical outcomes?
NJO Birkmeyer et al.
CANCER (2005)
Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy
RA Cowan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer:: Formal meta-analysis of comparative studies on tumor progression
A Böhle et al.
UROLOGY (2004)
Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer:: A combined analysis of two Nordic studies
A Sherif et al.
EUROPEAN UROLOGY (2004)
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
A Knight et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study
H Samaratunga et al.
HISTOPATHOLOGY (2004)
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2004)
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: A prospective randomized study
SM Di Stasi et al.
JOURNAL OF UROLOGY (2003)
Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer
JP Stein et al.
BJU INTERNATIONAL (2003)
Radical cystectomy for bladder cancer today - A homogeneous series without neoadjuvant therapy
S Madersbacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy
HW Herr
UROLOGY (2003)
Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors
AL Zietman et al.
JOURNAL OF UROLOGY (2003)
Occupation and bladder cancer among men in Western Europe
M Kogevinas et al.
CANCER CAUSES & CONTROL (2003)
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2002)
Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma
E Kaasinen et al.
EUROPEAN UROLOGY (2002)
Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance
TRL Griffiths et al.
JOURNAL OF UROLOGY (2002)
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies
M Brausi et al.
EUROPEAN UROLOGY (2002)
Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?
L Schips et al.
UROLOGY (2002)
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
HW Herr et al.
JOURNAL OF UROLOGY (2001)
The incidence of hematuria in middle distance track running
GR Jones et al.
CANADIAN JOURNAL OF APPLIED PHYSIOLOGY-REVUE CANADIENNE DE PHYSIOLOGIE APPLIQUEE (2001)
Upper urinary tract tumors after primary superficial bladder tumors:: Prognostic factors and risk groups
F Millán-Rodríguez et al.
JOURNAL OF UROLOGY (2000)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
DL Lamm et al.
JOURNAL OF UROLOGY (2000)
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
MH Khadra et al.
JOURNAL OF UROLOGY (2000)
NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population
PM Marcus et al.
PHARMACOGENETICS (2000)
Share Paper
